Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 340

1.

Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.

Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG.

Diagn Microbiol Infect Dis. 2013 Sep;77(1):37-40. doi: 10.1016/j.diagmicrobio.2013.05.019. Epub 2013 Jul 16.

PMID:
23870164
2.

Evaluation of the correlation of caspofungin MICs and treatment outcome in murine infections by wild type strains of Candida parapsilosis.

Salas V, Pastor FJ, Capilla J, Sutton DA, Mayayo E, Fothergill AW, Rinaldi MG, Guarro J.

Diagn Microbiol Infect Dis. 2013 Sep;77(1):41-5. doi: 10.1016/j.diagmicrobio.2013.05.011. Epub 2013 Jun 24.

PMID:
23806662
3.

MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.

Salas V, Pastor FJ, Sutton DA, Calvo E, Mayayo E, Fothergill AW, Rinaldi MG, Guarro J.

Antimicrob Agents Chemother. 2013 Mar;57(3):1532-4. doi: 10.1128/AAC.01436-12. Epub 2013 Jan 7.

4.

Are epidemiologic cut-off values predictors of the in vivo efficacy of azoles in experimental aspergillosis?

Calvo E, Pastor FJ, Sutton DA, Fothergill AW, Rinaldi MG, Salas V, Guarro J.

Diagn Microbiol Infect Dis. 2012 Oct;74(2):158-65. doi: 10.1016/j.diagmicrobio.2012.06.021. Epub 2012 Jul 31.

PMID:
22858549
5.

In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.

Salas V, Pastor FJ, Calvo E, Alvarez E, Sutton DA, Mayayo E, Fothergill AW, Rinaldi MG, Guarro J.

Antimicrob Agents Chemother. 2012 May;56(5):2246-50. doi: 10.1128/AAC.05956-11. Epub 2012 Jan 30.

6.

Correlation of susceptibility of Cryptococcus neoformans to amphotericin B with clinical outcome.

Larsen RA, Bauer M, Pitisuttithum P, Sanchez A, Tansuphaswadikul S, Wuthiekanun V, Peacock SJ, Simpson AJ, Fothergill AW, Rinaldi MG, Bustamante B, Thomas AM, Altomstone R, Day NP, White NJ.

Antimicrob Agents Chemother. 2011 Dec;55(12):5624-30. doi: 10.1128/AAC.00034-11. Epub 2011 Sep 26.

7.

Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp.

Peterson JF, Pfaller MA, Diekema DJ, Rinaldi MG, Riebe KM, Ledeboer NA.

J Clin Microbiol. 2011 May;49(5):1765-71. doi: 10.1128/JCM.02517-10. Epub 2011 Mar 23.

8.

Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.

Moriyama B, Ditullio M, Wilson E, Henning SA, Penzak SR, Danner RL, Pennick G, Rinaldi MG, Zelazny AM, Gea-Banacloche J, Barrett AJ, Walsh TJ.

Antimicrob Agents Chemother. 2011 May;55(5):2478-80. doi: 10.1128/AAC.01560-10. Epub 2011 Mar 14.

9.

Molecular and phenotypic characterization of Phialemonium and Lecythophora isolates from clinical samples.

Perdomo H, Sutton DA, García D, Fothergill AW, Gené J, Cano J, Summerbell RC, Rinaldi MG, Guarro J.

J Clin Microbiol. 2011 Apr;49(4):1209-16. doi: 10.1128/JCM.01979-10. Epub 2011 Jan 26.

10.

Spectrum of clinically relevant Acremonium species in the United States.

Perdomo H, Sutton DA, García D, Fothergill AW, Cano J, Gené J, Summerbell RC, Rinaldi MG, Guarro J.

J Clin Microbiol. 2011 Jan;49(1):243-56. doi: 10.1128/JCM.00793-10. Epub 2010 Nov 10.

11.

Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.

Alvarez E, Garcia-Hermoso D, Sutton DA, Cano JF, Stchigel AM, Hoinard D, Fothergill AW, Rinaldi MG, Dromer F, Guarro J.

J Clin Microbiol. 2010 Dec;48(12):4410-6. doi: 10.1128/JCM.01646-10. Epub 2010 Oct 6.

12.

High-molecular weight hyaluronan reduced renal PKC activation in genetically diabetic mice.

Campo GM, Avenoso A, Micali A, Nastasi G, Squadrito F, Altavilla D, Bitto A, Polito F, Rinaldi MG, Calatroni A, D'Ascola A, Campo S.

Biochim Biophys Acta. 2010 Nov;1802(11):1118-30. doi: 10.1016/j.bbadis.2010.08.004. Epub 2010 Aug 13.

13.

Internet-accessible DNA sequence database for identifying fusaria from human and animal infections.

O'Donnell K, Sutton DA, Rinaldi MG, Sarver BA, Balajee SA, Schroers HJ, Summerbell RC, Robert VA, Crous PW, Zhang N, Aoki T, Jung K, Park J, Lee YH, Kang S, Park B, Geiser DM.

J Clin Microbiol. 2010 Oct;48(10):3708-18. doi: 10.1128/JCM.00989-10. Epub 2010 Aug 4.

14.

Two new species of Mucor from clinical samples.

Alvarez E, Cano J, Stchigel AM, Sutton DA, Fothergill AW, Salas V, Rinaldi MG, Guarro J.

Med Mycol. 2011 Jan;49(1):62-72. doi: 10.3109/13693786.2010.499521. Epub 2010 Jul 22.

PMID:
20662633
15.

Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).

Espinel-Ingroff A, Diekema DJ, Fothergill A, Johnson E, Pelaez T, Pfaller MA, Rinaldi MG, Canton E, Turnidge J.

J Clin Microbiol. 2010 Sep;48(9):3251-7. doi: 10.1128/JCM.00536-10. Epub 2010 Jun 30.

16.

Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species.

Alvarez E, Stchigel AM, Cano J, Sutton DA, Fothergill AW, Chander J, Salas V, Rinaldi MG, Guarro J.

Rev Iberoam Micol. 2010 Jun 30;27(2):80-9. doi: 10.1016/j.riam.2010.01.006. Epub 2010 Mar 4.

17.

Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice.

Rodríguez MM, Pastor FJ, Sutton DA, Calvo E, Fothergill AW, Salas V, Rinaldi MG, Guarro J.

Antimicrob Agents Chemother. 2010 May;54(5):1665-9. doi: 10.1128/AAC.01463-09. Epub 2010 Feb 9.

18.

Pharmacokinetics of liposomal amphotericin B in pleural fluid.

Moriyama B, Torabi-Parizi P, Pratt AK, Henning SA, Pennick G, Shea YR, Roy Chowdhuri S, Rinaldi MG, Barrett AJ, Walsh TJ.

Antimicrob Agents Chemother. 2010 Apr;54(4):1633-5. doi: 10.1128/AAC.01438-09. Epub 2010 Jan 19.

19.

Sequence-based identification of filamentous basidiomycetous fungi from clinical specimens: a cautionary note.

Romanelli AM, Sutton DA, Thompson EH, Rinaldi MG, Wickes BL.

J Clin Microbiol. 2010 Mar;48(3):741-52. doi: 10.1128/JCM.01948-09. Epub 2009 Dec 30.

20.

Micafungin concentrations from brain tissue and pancreatic pseudocyst fluid.

Lat A, Thompson GR 3rd, Rinaldi MG, Dorsey SA, Pennick G, Lewis JS 2nd.

Antimicrob Agents Chemother. 2010 Feb;54(2):943-4. doi: 10.1128/AAC.01294-09. Epub 2009 Nov 23.

21.

Novel multilocus sequence typing scheme reveals high genetic diversity of human pathogenic members of the Fusarium incarnatum-F. equiseti and F. chlamydosporum species complexes within the United States.

O'Donnell K, Sutton DA, Rinaldi MG, Gueidan C, Crous PW, Geiser DM.

J Clin Microbiol. 2009 Dec;47(12):3851-61. doi: 10.1128/JCM.01616-09. Epub 2009 Oct 14.

22.

Cerebral aspergillosis caused by Aspergillus granulosus.

Sutton DA, Wickes BL, Romanelli AM, Rinaldi MG, Thompson EH, Fothergill AW, Dishop MK, Elidemir O, Mallory GB, Moonnamakal SP, Adesina AM, Schecter MG.

J Clin Microbiol. 2009 Oct;47(10):3386-90. doi: 10.1128/JCM.00588-09. Epub 2009 Aug 26.

23.

Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis.

Hickey PW, Sutton DA, Fothergill AW, Rinaldi MG, Wickes BL, Schmidt HJ, Walsh TJ.

J Clin Microbiol. 2009 Oct;47(10):3091-7. doi: 10.1128/JCM.00460-09. Epub 2009 Aug 5.

25.

Studies on peptidyl nucleoside antibiotics: synthesis and antifungal evaluation of pyranosyl nucleoside analogs of nikkomycin.

Stauffer CS, Fothergill AW, Rinaldi MG, Dutta A.

Future Med Chem. 2009 May;1(2):379-89. doi: 10.4155/fmc.09.18.

PMID:
21425974
26.

Spectrum of zygomycete species identified in clinically significant specimens in the United States.

Alvarez E, Sutton DA, Cano J, Fothergill AW, Stchigel A, Rinaldi MG, Guarro J.

J Clin Microbiol. 2009 Jun;47(6):1650-6. doi: 10.1128/JCM.00036-09. Epub 2009 Apr 22.

27.

Cutaneous infection caused by Macrophomina phaseolina in a child with acute myeloid leukemia.

Srinivasan A, Wickes BL, Romanelli AM, Debelenko L, Rubnitz JE, Sutton DA, Thompson EH, Fothergill AW, Rinaldi MG, Hayden RT, Shenep JL.

J Clin Microbiol. 2009 Jun;47(6):1969-72. doi: 10.1128/JCM.02397-08. Epub 2009 Apr 22.

28.

Taxonomy and phylogeny of the Fusarium dimerum species group.

Schroers HJ, O'Donnell K, Lamprecht SC, Kammeyer PL, Johnson S, Sutton DA, Rinaldi MG, Geiser DM, Summerbell RC.

Mycologia. 2009 Jan-Feb;101(1):44-70.

PMID:
19271670
29.

Posaconazole therapeutic drug monitoring: a reference laboratory experience.

Thompson GR 3rd, Rinaldi MG, Pennick G, Dorsey SA, Patterson TF, Lewis JS 2nd.

Antimicrob Agents Chemother. 2009 May;53(5):2223-4. doi: 10.1128/AAC.00240-09. Epub 2009 Mar 2. No abstract available.

30.

Accelerated metabolism of voriconazole and its partial reversal by cimetidine.

Moriyama B, Elinoff J, Danner RL, Gea-Banacloche J, Pennick G, Rinaldi MG, Walsh TJ.

Antimicrob Agents Chemother. 2009 Apr;53(4):1712-4. doi: 10.1128/AAC.01221-08. Epub 2009 Jan 26.

31.

Isolation and characterization of a new fungal species, Chrysosporium ophiodiicola, from a mycotic granuloma of a black rat snake (Elaphe obsoleta obsoleta).

Rajeev S, Sutton DA, Wickes BL, Miller DL, Giri D, Van Meter M, Thompson EH, Rinaldi MG, Romanelli AM, Cano JF, Guarro J.

J Clin Microbiol. 2009 Apr;47(4):1264-8. doi: 10.1128/JCM.01751-08. Epub 2008 Dec 24.

32.

Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.

Fothergill AW, Rinaldi MG, Sutton DA.

Med Mycol. 2009 Feb;47(1):41-3. doi: 10.1080/13693780802512451. Epub 2008 Dec 12.

PMID:
19107637
33.

Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.

Brzankalski GE, Najvar LK, Wiederhold NP, Bocanegra R, Fothergill AW, Rinaldi MG, Pattterson TF, Graybill JR.

J Antimicrob Chemother. 2008 Nov;62(5):1094-100. doi: 10.1093/jac/dkn304. Epub 2008 Jul 25.

34.

Transplant-associated Ochroconis gallopava infections.

Shoham S, Pic-Aluas L, Taylor J, Cortez K, Rinaldi MG, Shea Y, Walsh TJ.

Transpl Infect Dis. 2008 Dec;10(6):442-8. doi: 10.1111/j.1399-3062.2008.00327.x. Epub 2008 Jul 22.

PMID:
18651872
35.

Persistent pulmonary infection with an azole-resistant Coccidioides species.

Kriesel JD, Sutton DA, Schulman S, Fothergill AW, Rinaldi MG.

Med Mycol. 2008 Sep;46(6):607-10. doi: 10.1080/13693780802140923.

PMID:
18608910
36.

Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex.

O'Donnell K, Sutton DA, Fothergill A, McCarthy D, Rinaldi MG, Brandt ME, Zhang N, Geiser DM.

J Clin Microbiol. 2008 Aug;46(8):2477-90. doi: 10.1128/JCM.02371-07. Epub 2008 Jun 4.

37.

Pulmonary Phialemonium curvatum phaeohyphomycosis in a Standard Poodle dog.

Sutton DA, Wickes BL, Thompson EH, Rinaldi MG, Roland RM, Libal MC, Russell K, Gordon S.

Med Mycol. 2008 Jun;46(4):355-9. doi: 10.1080/13693780701861470.

PMID:
18415843
38.

In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.

Azor M, Gené J, Cano J, Sutton DA, Fothergill AW, Rinaldi MG, Guarro J.

Antimicrob Agents Chemother. 2008 Jun;52(6):2228-31. doi: 10.1128/AAC.00176-08. Epub 2008 Apr 7.

39.

Cutaneous infection with Metarhizium anisopliae in a patient with hypohidrotic ectodermal dysplasia and immune deficiency.

Marsh RA, Lucky AW, Walsh TJ, Pacheco MC, Rinaldi MG, Mailler-Savage E, Puel A, Casanova JL, Bleesing JJ, Filippi MD, Williams DA, Daines MO, Filipovich AH.

Pediatr Infect Dis J. 2008 Mar;27(3):283-4. doi: 10.1097/INF.0b013e31816459ce. No abstract available.

PMID:
18277915
40.

Infections caused by Scedosporium spp.

Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, Buchanan W, Milanovich J, Sutton DA, Fothergill A, Rinaldi MG, Shea YR, Zaoutis T, Kottilil S, Walsh TJ.

Clin Microbiol Rev. 2008 Jan;21(1):157-97. doi: 10.1128/CMR.00039-07. Review.

41.

Total synthesis and antifungal activity of a carbohydrate ring-expanded pyranosyl nucleoside analogue of nikkomycin B.

Stauffer CS, Bhaket P, Fothergill AW, Rinaldi MG, Datta A.

J Org Chem. 2007 Dec 21;72(26):9991-7. Epub 2007 Nov 15.

PMID:
18001102
43.

Spectrum of clinically relevant Exophiala species in the United States.

Zeng JS, Sutton DA, Fothergill AW, Rinaldi MG, Harrak MJ, de Hoog GS.

J Clin Microbiol. 2007 Nov;45(11):3713-20. Epub 2007 Jun 27.

44.

Trailing end-point phenotype of Candida spp. in antifungal susceptibility testing to fluconazole is eliminated by altering incubation temperature.

Agrawal D, Patterson TF, Rinaldi MG, Revankar SG.

J Med Microbiol. 2007 Jul;56(Pt 7):1003-4. No abstract available.

PMID:
17577072
45.

Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.

Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller MA, Rinaldi MG, Schell W, Walsh TJ.

J Clin Microbiol. 2007 Jul;45(7):2180-2. Epub 2007 May 2.

46.

In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.

Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S.

Antimicrob Agents Chemother. 2007 Jul;51(7):2587-90. Epub 2007 Apr 23.

47.
48.

Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes.

Ferguson TD, Schniederjan SD, Dionne-Odom J, Brandt ME, Rinaldi MG, Nolte FS, Langston A, Zimmer SM.

J Clin Microbiol. 2007 May;45(5):1648-51. Epub 2007 Mar 7.

49.
50.

Posaconazole prophylaxis in experimental systemic zygomycosis.

Barchiesi F, Spreghini E, Santinelli A, Fothergill AW, Pisa E, Giannini D, Rinaldi MG, Scalise G.

Antimicrob Agents Chemother. 2007 Jan;51(1):73-7. Epub 2006 Oct 23.

Supplemental Content

Loading ...
Support Center